Patents by Inventor Norifumi Tateishi
Norifumi Tateishi has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 10342773Abstract: The present invention provides a composition, such as a food and pharmaceutical agent, which comprises dihomo-?-linolenic acid, and which has the effect of preventing or treating skin diseases; a composition such as a food and pharmaceutical agent which comprises dihomo-?-linolenic acid and which has the effect of preventing or treating skin diseases; and a composition which comprises dihomo-?-linolenic acid and which has the effect of preventing or treating diseases related to increased mast cell count.Type: GrantFiled: March 5, 2018Date of Patent: July 9, 2019Assignee: SUNTORY HOLDINGS LIMITEDInventors: Norifumi Tateishi, Hiroshi Kawashima
-
Publication number: 20180193298Abstract: The present invention provides a composition, such as a food and pharmaceutical agent, which comprises dihomo-?-linolenic acid, and which has the effect of preventing or treating skin diseases; a composition such as a food and pharmaceutical agent which comprises dihomo-?-linolenic acid and which has the effect of preventing or treating skin diseases; and a composition which comprises dihomo-?-linolenic acid and which has the effect of preventing or treating diseases related to increased mast cell count.Type: ApplicationFiled: March 5, 2018Publication date: July 12, 2018Applicant: SUNTORY HOLDINGS LIMITEDInventors: Norifumi TATEISHI, Hiroshi KAWASHIMA
-
Patent number: 9943495Abstract: The present invention provides a composition, such as a food and pharmaceutical agent, which comprises dihomo-?-linolenic acid, and which has the effect of preventing or treating skin diseases; a composition such as a food and pharmaceutical agent which comprises dihomo-?-linolenic acid and which has the effect of preventing or treating skin diseases; and a composition which comprises dihomo-?-linolenic acid and which has the effect of preventing or treating diseases related to increased mast cell count.Type: GrantFiled: March 11, 2015Date of Patent: April 17, 2018Assignee: SUNTORY HOLDINGS LIMITEDInventors: Norifumi Tateishi, Hiroshi Kawashima
-
Publication number: 20180071248Abstract: The purporse of the present invention is to provide a circadian rhythm improving composition which can be safely taken over a long time, in particular, a circadian rhythm controlling composition capable of increasing circadian rhythm amplitude. Provided is a circadian rhythm improving composition comprising one or more kindes of lignan compounds.Type: ApplicationFiled: March 22, 2016Publication date: March 15, 2018Applicant: SUNTORY HOLDINGS LIMITEDInventors: Norifumi TATEISHI, Shigenobu SHIBATA
-
Patent number: 9895375Abstract: The present invention relates to a composition containing riboflavin and a sesamin-class compound(s). This composition may incorporate a sesamin-class compound(s) in such an amount that the proportion (weight ratio) of its total quantity to the total quantity of riboflavin taken as unity is no more than 4.5, and it has the advantage that the analgesic and anti-fatigue actions of riboflavin are synergistically improved by ingestion of riboflavin in combination with a sesamin-class compound(s). The composition of the present invention provides compositions, in particular, pharmaceuticals as well as foods and beverages that are safe to humans, animals, etc., and can therefore be ingested for a continued period, and which have far superior effects to those of conventional foods having an analgesic or anti-fatigue action.Type: GrantFiled: November 24, 2014Date of Patent: February 20, 2018Assignee: SUNTORY HOLDINGS LIMITEDInventors: Daisuke Takemoto, Norifumi Tateishi, Yoshiko Ono, Kayo Saito, Akifumi Maeda
-
Patent number: 9609884Abstract: Anti-fatigue agents containing dioxabicyclo[3.3.0]octane derivatives such as sesamin which is an ingredient contained in sesame, as well as pharmaceutical compositions and physiologically functional foods that contain such anti-fatigue agents are disclosed. These compounds can safely be administered to humans and animals alike and hence allow for continued ingestion while proving effective in promoting an improvement of stamina, an increase of body strength, a relief of fatigue, and recovery from fatigue.Type: GrantFiled: March 12, 2008Date of Patent: April 4, 2017Assignee: Suntory Holdings LimitedInventors: Yoshiko Ono, Kayo Saito, Norifumi Tateishi, Akifumi Maeda
-
Publication number: 20150182486Abstract: The present invention provides a composition, such as a food and pharmaceutical agent, which comprises dihomo-?-linolenic acid, and which has the effect of preventing or treating skin diseases; a composition such as a food and pharmaceutical agent which comprises dihomo-?-linolenic acid and which has the effect of preventing or treating skin diseases; and a composition which comprises dihomo-?-linolenic acid and which has the effect of preventing or treating diseases related to increased mast cell count.Type: ApplicationFiled: March 11, 2015Publication date: July 2, 2015Applicant: SUNTORY HOLDINGS LIMITEDInventors: Norifumi TATEISHI, Hiroshi KAWASHIMA
-
Patent number: 9006287Abstract: The present invention provides a composition, such as a food and pharmaceutical agent, which comprises dihomo-?-linolenic acid, and which has the effect of preventing or treating skin diseases; a composition such as a food and pharmaceutical agent which comprises dihomo-?-linolenic acid and which has the effect of preventing or treating skin diseases; and a composition which comprises dihomo-?-linolenic acid and which has the effect of preventing or treating diseases related to increased mast cell count.Type: GrantFiled: February 10, 2006Date of Patent: April 14, 2015Assignee: Suntory Holdings LimitedInventors: Norifumi Tateishi, Hiroshi Kawashima
-
Publication number: 20150080407Abstract: The present invention relates to a composition containing riboflavin and a sesamin-class compound(s). This composition may incorporate a sesamin-class compound (s) in such an amount that the proportion (weight ratio) of its total quantity to the total quantity of riboflavin taken as unity is no more than 4.5, and it has the advantage that the analgesic and anti-fatigue actions of riboflavin are synergistically improved by ingestion of riboflavin in combination with a sesamin-class compound(s). The composition of the present invention provides compositions, in particular, pharmaceuticals as well as foods and beverages that are safe to humans, animals, etc. and can therefore be ingested for a continued period, and which have far superior effects to those of conventional foods having an analgesic or anti-fatigue action.Type: ApplicationFiled: November 24, 2014Publication date: March 19, 2015Applicant: SUNTORY HOLDINGS LIMITEDInventors: Daisuke TAKEMOTO, Norifumi TATEISHI, Yoshiko ONO, Kayo SAITO, Akifumi MAEDA
-
Patent number: 8507547Abstract: Disclosed is a composition which is safe for a human body and an animal, can be ingested continuously on a daily basis, has an anti-fatigue activity, and is effective for the prevention or treatment of a disease or condition associated with fatigue. Specifically disclosed is an anti-fatigue agent comprising andrographolide optionally together with an ?-lipoic acid as an active ingredient(s). Also disclosed is a novel oral composition comprising andrographolide and an ?-lipoic acid. The anti-fatigue agent and the oral composition are useful for the prevention or treatment of chronic fatigue syndrome, overfatigue, physical fatigue, mental fatigue and organ fatigue.Type: GrantFiled: May 30, 2008Date of Patent: August 13, 2013Assignee: Suntory Holdings LimitedInventors: Sumio Asami, Kayo Saito, Akifumi Maeda, Norifumi Tateishi
-
Publication number: 20100144866Abstract: Disclosed is a composition which is safe for a human body and an animal, can be ingested continuously on a daily basis, has an anti-fatigue activity, and is effective for the prevention or treatment of a disease or condition associated with fatigue. Specifically disclosed is an anti-fatigue agent comprising andrographolide optionally together with an ?-lipoic acid as an active ingredient(s). Also disclosed is a novel oral composition comprising andrographolide and an ?-lipoic acid. The anti-fatigue agent and the oral composition are useful for the prevention or treatment of chronic fatigue syndrome, overfatigue, physical fatigue, mental fatigue and organ fatigue.Type: ApplicationFiled: May 30, 2008Publication date: June 10, 2010Applicant: Suntory Holdings LimitedInventors: Sumio Asami, Kayo Saito, Akifumi Maeda, Norifumi Tateishi
-
Publication number: 20100048695Abstract: Anti-fatigue agents containing dioxabicyclo[3.3.0]octane derivatives such as sesamin which is an ingredient contained in sesame, as well as pharmaceutical compositions and physiologically functional foods that contain such anti-fatigue agents are disclosed. These compounds can safely be administered to humans and animals alike and hence allow for continued ingestion while proving effective in promoting an improvement of stamina, an increase of body strength, a relief of fatigue, and recovery from fatigue.Type: ApplicationFiled: March 12, 2008Publication date: February 25, 2010Inventors: Yoshiko Ono, Kayo Saito, Norifumi Tateishi, Akifumi Maeda
-
Publication number: 20090143317Abstract: The present invention provides an ?-glycosyl isoquercitrin-containing novel composition which has a high in vivo absorbability, and hence exhibits a significant in vivo antioxidative activity. The present invention further provides preparation methods for such a composition. The composition contains a mixture of quercetin glycosides represented by the following formula: wherein Glc represents a glucose residue, and n is 0 or a positive integer of 1 or more, includes at least a quercetin glycoside wherein n is 3, and satisfies the following requirement (a): (a) the total proportion of quercetin glycosides in which n is 3, and in which other n values may be 1 or 2, or 1 and 2, is 50 mol % or more, and the total proportion of quercetin glycosides wherein n is 4 or more is 15 mol % or less, in the composition. The composition can be prepared by treating an enzymatically modified isoquercitrin with ?-amylase.Type: ApplicationFiled: December 28, 2005Publication date: June 4, 2009Applicants: Suntory Limited, SAN-EI GEN F.F.I., INC.Inventors: Yoshiko Ono, Namino Tomimori, Norifumi Tateishi, Masamitsu Moriwaki, Kazuhiro Emura, Shuji Okuyama
-
Publication number: 20090054443Abstract: The present invention relates to a composition containing riboflavin and a sesamin-class compound(s). This composition may incorporate a sesamin-class compound(s) in such an amount that the proportion (weight ratio) of its total quantity to the total quantity of riboflavin taken as unity is no more than 4.5, and it has the advantage that the analgesic and anti-fatigue actions of riboflavin are synergistically improved by ingestion of riboflavin in combination with a sesamin-class compound(s). The composition of the present invention provides compositions, in particular, pharmaceuticals as well as foods and beverages that are safe to humans, animals, etc. and can therefore be ingested for a continued period, and which have far superior effects to those of conventional foods having an analgesic or anti-fatigue action.Type: ApplicationFiled: March 15, 2007Publication date: February 26, 2009Applicant: SUNTORY LIMITEDInventors: Daisuke Takemoto, Norifumi Tateishi, Yoshiko Ono, Kayo Saito, Akifumi Maeda
-
Publication number: 20080108699Abstract: The present invention provides a composition, such as a food and pharmaceutical agent, which comprises dihomo-?-linolenic acid, and which has the effect of preventing or treating skin diseases; a composition such as a food and pharmaceutical agent which comprises dihomo-?-linolenic acid and which has the effect of preventing or treating skin diseases; and a composition which comprises dihomo-?-linolenic acid and which has the effect of preventing or treating diseases related to increased mast cell count.Type: ApplicationFiled: February 10, 2006Publication date: May 8, 2008Applicant: SUNTORY LIMITEDInventors: Norifumi Tateishi, Hiroshi Kawashima
-
Publication number: 20050163831Abstract: A patch for transdermal administration having a sufficiently high transdermal permeation property of a COX-2 inhibitor to exert a superior antiinflammatory effect, the patch for transdermal administration comprising a backing and an adhesive layer which is placed on at least one side of the backing and comprises an adhesive base agent and a drug, wherein the drug is valdecoxib or a pharmaceutically acceptable salt thereof.Type: ApplicationFiled: February 1, 2005Publication date: July 28, 2005Applicant: Hisamitsu Pharmaceutical Co., Inc.Inventors: Atsutoshi Ikesue, Norifumi Tateishi, Kengo Uemura, Takaaki Terahara, Naruhito Higo, Michinori Sakai